KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Cash & Current Investments (2016 - 2025)

Encompass Health (EHC) has disclosed Cash & Current Investments for 17 consecutive years, with $102.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments fell 16.41% year-over-year to $102.9 million, compared with a TTM value of $102.9 million through Dec 2025, down 16.41%, and an annual FY2025 reading of $102.9 million, down 16.41% over the prior year.
  • Cash & Current Investments was $102.9 million for Q4 2025 at Encompass Health, up from $48.7 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $286.1 million in Q1 2021 and bottomed at $48.7 million in Q3 2025.
  • Average Cash & Current Investments over 5 years is $131.5 million, with a median of $128.5 million recorded in 2022.
  • The sharpest move saw Cash & Current Investments plummeted 72.54% in 2021, then surged 103.18% in 2024.
  • Year by year, Cash & Current Investments stood at $111.9 million in 2021, then crashed by 52.28% to $53.4 million in 2022, then surged by 95.13% to $104.2 million in 2023, then increased by 18.14% to $123.1 million in 2024, then dropped by 16.41% to $102.9 million in 2025.
  • Business Quant data shows Cash & Current Investments for EHC at $102.9 million in Q4 2025, $48.7 million in Q3 2025, and $99.1 million in Q2 2025.